Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > University of Texas at Austin Licenses Technology For Nanoparticle Detection to Houston Company

Abstract:
Technology that can determine the concentration of nanomaterials in living tissue has been licensed by The University of Texas at Austin to Houston-based nanoTox Inc.

The technology comes from the laboratory of Dr. James Tunnell, an assistant professor in the Department of Biomedical Engineering in the Cockrell School of Engineering. Tunnell's lab focuses on developing minimally invasive optical technologies for the detection, diagnosis and treatment of disease, particularly for application to cancer screening and therapeutics.

University of Texas at Austin Licenses Technology For Nanoparticle Detection to Houston Company

Austin, TX | Posted on September 29th, 2008

Nanoparticles are pure chemical or molecular materials smaller than one-tenth of a micrometer that are increasingly being used in a variety of applications, including medical devices, medicines and cosmetics.

In developing safe and effective products, one concern is knowing what becomes of nanoparticles applied or administered to the body. For example, nanoparticles designed to concentrate in certain locations such as tumor tissue for diagnostic or therapeutic purposes must not accumulate in other healthy tissues where they might cause harm such as the brain, heart, liver or kidneys.

Tunnell's tool, which employs optical spectroscopy, provides a non-invasive way for companies who use nanoparticles in their products to tell whether those particles remain in tissue or have been flushed out.

"This uses an optical fiber that you just place in contact with the tissue and the light makes a measurement in a non-invasive way," Tunnell said.

The current method for measuring nanoparticles at diagnostic or therapeutic concentrations in tissue typically involves the administration of radioisotopes or invasive procedures requiring a biopsy followed by time-consuming and costly examination using specialized forms of electron microscopy, X-ray analysis or nuclear chemical analysis in some cases.

"Dr. Tunnell has created a very minimally invasive technique to detect nanoparticles in tissue relatively simply and economically," said Greg King, vice president and chief operating officer of nanoTox®.

As a detection tool, it "will answer a lot of questions that government agencies and consumers are asking about nanomaterials," Harry Bushong, the company's president, said.

The license grants nanoTox® exclusive worldwide rights to the technology which includes the development of medical diagnostic applications. The company also plans to further develop the technology for other uses such as the nanotechnology risk-assessment market.

Nanotox has laboratory and research operations in Austin.

The company's chief scientific officer, Dr. David Hobson, said that working with Tunnell and his laboratory staff should lead to the development of this promising technology into a valuable tool for medical and nanotechnology safety assessment applications.

Understanding the risks from exposure to nanomaterials helps to satisfy international product liability insurers that support the development of beneficial applications of nanotechnology.

The company's scientists consult with engineers, chemists and other nanomaterial developers to identify and either eliminate or reduce significant toxicity found in a nanomaterial, thereby improving the safety of nanomaterials for customers, employees and the environment.

####

For more information, please click here

Contacts:
Tim Green
Office of the Vice President for Research
512-475-6596


Bill Stahl
nanoTox Inc.
512-804-2800

Copyright © University of Texas at Austin

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Biophotonics Laboratory

Department of Biomedical Engineering

Office of Technology Commercialization

nanoTox Inc.

Related News Press

News and information

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

Vacuum Ultraviolet Lamp of the Future Created in Japan: First Solid-State Vacuum UV Phosphor, Described in APL-Materials, Promises Smaller, Safer, Longer Lasting, Low Power Lamps for Industrial Applications April 22nd, 2014

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

Nanomedicine

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Amino-functionalized carbon nanotubes act as a carrier for nerve growth factor April 21st, 2014

Newly-Produced Bone Cement Able to Carry Medicine April 21st, 2014

Announcements

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

Safety-Nanoparticles/Risk management

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Effects of Carbon Nanotubes Studied on Pregnant Mothers April 12th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE